» Articles » PMID: 37171770

Low- and High-frequency Spinal Cord Stimulation and Arterial Blood Pressure in Patients with Chronic Pain and Hypertension: a Retrospective Study

Overview
Journal Clin Auton Res
Date 2023 May 12
PMID 37171770
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Evidence suggests that traditional low-frequency spinal cord stimulation (LF-SCS) reduces arterial blood pressure (BP) in patients with chronic pain and hypertension independent of improved pain symptoms. However, it remains unclear whether high-frequency spinal cord stimulation (HF-SCS) also lowers BP in chronic pain patients with hypertension. Therefore, in a retrospective study design, we tested the hypothesis that clinic BP would be significantly reduced following implantation of HF-SCS in patients with chronic pain and hypertension.

Methods: Clinic BP within 3 months before and after surgical implantation of either a LF-SCS or HF-SCS device between 2010 and 2020 were collected from electronic medical records at The University of Kansas Health System (TUKHS).

Results: A total of 132 patients had available records of clinic BP (64 ± 13 years of age). Patients with hypertension (n = 32) demonstrated a significantly greater reduction in systolic BP (-8 ± 12 versus 2 ± 9 mmHg, P < 0.001) following implantation compared with normotensive patients (n = 100). Importantly, the change in BP was inversely related to baseline BP independent of age and sex following implantation of HF-SCS (n = 70, R =  -0.50, P < 0.001) or LF-SCS (n = 62, R =  -0.42, P = 0.001). Higher pain scores before implantation were not associated with reduction in systolic BP (R = 0.10, P = 0.43) or diastolic BP (R =  -0.08, P = 0.53) (n = 69) after implantation.

Conclusion: These findings confirm previous studies showing reduced BP following implantation of LF-SCS in patients with chronic pain and hypertension and provide novel data regarding reduced BP following implantation of newer generation HF-SCS devices.

Citing Articles

Clinical trials in neuromodulatory treatment of drug-resistant hypertension and the need for spinal cord stimulation trials: a PRISMA systematic review.

Thrash G, Wang E, Sun Y, Walker H, Shirvalkar P, Becker B Bioelectron Med. 2024; 10(1):28.

PMID: 39617923 PMC: 11610299. DOI: 10.1186/s42234-024-00160-7.


Effect of neuromodulation for chronic pain on the autonomic nervous system: a systematic review.

Billet B, Goudman L, Rigoard P, Billot M, Roulaud M, Verstraete S BJA Open. 2024; 11:100305.

PMID: 39319097 PMC: 11419894. DOI: 10.1016/j.bjao.2024.100305.

References
1.
Anderson E, Sinkey C, Lawton W, Mark A . Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989; 14(2):177-83. DOI: 10.1161/01.hyp.14.2.177. View

2.
Bruehl S, Chung O, Jirjis J, Biridepalli S . Prevalence of clinical hypertension in patients with chronic pain compared to nonpain general medical patients. Clin J Pain. 2005; 21(2):147-53. DOI: 10.1097/00002508-200503000-00006. View

3.
Eckermann J, Pilitsis J, Vannaboutathong C, Wagner B, Province-Azalde R, Bendel M . Systematic Literature Review of Spinal Cord Stimulation in Patients With Chronic Back Pain Without Prior Spine Surgery. Neuromodulation. 2021; . DOI: 10.1111/ner.13519. View

4.
Epstein L, Palmieri M . Managing chronic pain with spinal cord stimulation. Mt Sinai J Med. 2012; 79(1):123-32. DOI: 10.1002/msj.21289. View

5.
Goudman L, Brouns R, Linderoth B, Moens M . Effects of spinal cord stimulation on heart rate variability in patients with Failed Back Surgery Syndrome. PLoS One. 2019; 14(7):e0219076. PMC: 6602188. DOI: 10.1371/journal.pone.0219076. View